Review Article

Nano-Based Anti-Tubercular Drug Delivery and Therapeutic Interventions in Tuberculosis

Author(s): Rohit Sharma, Amanpreet Kaur, A. K. Sharma, Neeraj Dilbaghi and Anil K. Sharma

Volume 18, Issue 1, 2017

Page: [72 - 86] Pages: 15

DOI: 10.2174/1389450116666150804110238

Price: $65

Abstract

Nanotechnology has shown great promise in health care offering numerous possibilities to significantly improve diagnosis of many dreadful diseases including Tuberculosis (TB). Nanomedicine has made the current drug regimen more effective against diseases particularly TB with attributes like sustained release, increased half life, higher drug concentrations at target sites, reduced toxicity and lesser side effects. However because of the severity of the disease, there is a strong urge to develop better approaches with some concomitant regimens using nano-particles to diagnose, treat and manage TB patients. The current review highlights some of the evolving strategies in the field of nanomedicine particularly drug delivery offering promising alternative for the current TB regimens. The study also emphasizes upon the need to design more effective nanocarriers which are highly specific, biocompatible and biodegradable as well.

Keywords: Nanomedicine, TB, nanocarriers, drugs, drug regimen.


Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy